Home  >  Products  >  Influenza A, H1N1, Reassortant (Influenza A Strain A/California/7/2009 NYMC X-179A, H1N1)

Influenza A, H1N1, Reassortant (Influenza A Strain A/California/7/2009 NYMC X-179A, H1N1)

Cat no: I7650-17R


Supplier: United States Biological
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
Attenuated reassortant vaccine candidate strain of reduced pathogenicity relative to the wild type A/California/4/2009 virus. Contains a high concentration of viral antigens as well as some egg proteins (Allantoic fluid). Reassortant virus includes genetic components of the H1N1 influenza pandemic swine flu in a culture-adapted virus that has been selected for its qualities as a vaccine-producing strain. Inactivation: Gamma radiation inactivation. The effectiveness of inactivation is shown when there is no detection of growth in two blind passages under standard cell culture conditions (MDCK cells). No live virus is detected by either CPE or HA Assay. Result: No growth detected. Storage and Stability: Aliquot to avoid repeated freezing and thawing and store at -70 degrees C. Aliquots are stable for 6 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Catalogue number: I7650-17R
Size: 1ml
Form: Supplied as a liquid.
Purity: Eggs are infected by injection into the Allantoic chamber, incubated for 72 hours, and refrigerated overnight prior to harvest. Allantoic fluids are harvested from the eggs and pooled.

Get Quote

  • Best Price Guaranteed
  • Quick Response Time
  • Exclusive Promotions
Enquiry_down_arrow
United States Biological
Get a Quote Direct from
United States Biological

By submitting this form you agree to your details being passed to United States Biological for the purpose of generating the best quote*

Button_on Button_off_biosave Button_off_biosave Button_off_biosave Button_off_biosave Button_off_biosave Button_off_biosave